A detailed history of Federated Hermes, Inc. transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 12,852,654 shares of RGLS stock, worth $19.7 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
12,852,654
Previous 12,852,654 -0.0%
Holding current value
$19.7 Million
Previous $23 Million 12.29%
% of portfolio
0.05%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$1.13 - $2.88 $10.1 Million - $25.9 Million
8,977,076 Added 231.63%
12,852,654 $37 Million
Q2 2023

Aug 14, 2023

BUY
$0.87 - $1.75 $844,554 - $1.7 Million
970,752 Added 33.42%
3,875,578 $5.7 Million
Q2 2022

Sep 16, 2022

SELL
$1.6 - $3.4 $4.24 Million - $9.01 Million
-2,650,729 Reduced 47.71%
2,904,826 $6.01 Million
Q2 2022

Aug 15, 2022

BUY
$1.6 - $3.4 $8.89 Million - $18.9 Million
5,555,555 New
5,555,555 $11.5 Million

Others Institutions Holding RGLS

About Regulus Therapeutics Inc.


  • Ticker RGLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,634,400
  • Market Cap $22.4M
  • Description
  • Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...
More about RGLS
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.